Connect with us

Technology

UBC AND THREAD EXPAND SITEPLUS OFFERING AND ACTIVE STUDIES WITH BIOPHARMA SPONSORS TO OPTIMIZE EVIDENCE GENERATION

Published

on

Collaboration augments full-featured central site model with additional research services and technology to widen recruitment access and improve the site and patient experience

KING OF PRUSSIA, Pa. and CARY, N.C., June 25, 2024 /PRNewswire/ — United BioSource LLC (UBC), a leading provider of evidence development solutions, and Thread®, a leading decentralized research, electronic clinical outcome assessment (eCOA) and consulting services provider, today announced the expansion of their SitePlus solution. This joint offering, the outcome of a successful six-year working relationship, has provided early recruitment and retention success for biopharma customers since its March 2023 launch. UBC and Thread have now expanded the solution to offer additional central site services and technology features for both post-approval research and Phase II/III interventional clinical trials.

SitePlus provides a next-generation research model that can be initiated from initial study design and launch or added alongside any ongoing Phase II-IV study nationwide. SitePlus offers a central site model which extends the reach of sites and widens the addressable patient population. The solution leverages a centralized technology platform to accelerate patient recruitment, facilitate home health engagement, securely capture data, and enable superior patient retention.

SitePlus combines UBC’s industry leading late-stage research solutions with Thread’s technology to empower central site study designs focused on patients while improving the research experience for all participating sites. It further enables biopharma sponsors to contract with UBC as a central research center inclusive of investigator and study coordinating center concierge support services. SitePlus connects UBC’s central principal investigator, home health, and patient coordinating center expertise with Thread’s unified technology platform and consulting services for data capture, virtual visits, and optimized patient engagement.

“Study designs that rely exclusively on brick-and-mortar site models can benefit from the enhancements SitePlus offers to help meet their patient enrollment and retention goals,” said Bekki Bracken Brown, President & Chief Executive Officer, UBC. “Studies leveraging a hybrid approach have seen success in reaching a more representative patient population, faster, and maintaining patient engagement. The Thread technology platform supports our central site offering by enabling a more flexible approach to patient recruitment and engagement and strengthens the return on evidence generation for our customers. “

UBC and Thread’s enterprise collaboration continues to enrich UBC’s modernized study designs and eCOA solutions that enable patient-centered research studies to be conducted in the clinic, in the home, and on-the-go.

“Based on strong early results with SitePlus for our joint customers, we are excited to expand its features to offer solutions in both interventional and post-approval research studies,” said Thread Co-Founder and CEO John Reites. “We appreciate UBC’s continued partnership and the feedback from our biopharma customers to add more value to this important innovative offering’s market growth.”

Learn more about SitePlus at www.AddSitePlus.com

About UBC
United BioSource LLC (UBC) is the leading provider of evidence development solutions with expertise in uniting evidence and access. UBC helps biopharma mitigate risk, address product hurdles, and demonstrate safety, efficacy, and value under real-world conditions. Underpinned by our scientific expertise, data and analytics, and innovative technologies, we offer our customers flexible solutions generating the relevant real-world data necessary to make more informed decisions earlier, meet stakeholder requirements, and, ultimately, drive better patient outcomes. For additional information, visit www.ubc.com.

About Thread
Thread’s® purpose is to leverage its decentralized research platform to enable studies for everyone, everywhere. The company’s uniquely combined clinical research technology and consulting services help life science organizations to design, operate, and scale next-generation research studies and electronic clinical outcome assessments (eCOA) programs for participants, sites, and study teams. Through its comprehensive platform and scientific expertise, Thread empowers studies to be accessible, efficient, and centered on the patient. Backed by health care investors Water Street Healthcare Partners and JLL Partners, Thread is recognized as a leader by Everest Group’s Decentralized Clinical Trial Product PEAK Matrix® Assessment 2021/2022 and positioned in the Leader’s Category of the 2022 IDC MarketScape for R&D Decentralized Clinical Trial Technology Solutions Vendor Assessment 2022. Visit Threadresearch.com to learn more. 

View original content to download multimedia:https://www.prnewswire.com/news-releases/ubc-and-thread-expand-siteplus-offering-and-active-studies-with-biopharma-sponsors-to-optimize-evidence-generation-302173322.html

SOURCE UBC; Thread

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

iSOFT Contributes Intelligent Driving OS as AUTOSAR CAPI Global Code Baseline

Published

on

By

SHANGHAI, June 16, 2026 /PRNewswire/ — At the 17th AUTOSAR Open Conference (AOC) in Shanghai, iSOFT (iSOFT Infrastructure Software Co., Ltd.) contributed its self-developed intelligent driving operating system as the global code baseline for AUTOSAR’s Common Adaptive Platform Implementation (CAPI) – a notable milestone in the evolution of the global smart vehicle industry.

“This is a paradigm shift from ‘standard-first’ to ‘code-first,’ responding to new industrial demands of the intelligent connected era,” said Liu Hongqian, General Manager of iSOFT. “Open source enables collaboration but must meet automotive-grade safety and performance requirements. iSOFT was the first to open-source EasyXMen, and CAPI reinforces our commitment. As the first international code standard baseline from a Chinese enterprise, this is Chinese wisdom going global. CAPI lets global enterprises develop on one codebase, significantly reducing adaptation costs.”

Joachim Langenwalter, AUTOSAR spokesperson, underscored China’s lead: “China is the world’s largest automotive market at 30 million vehicles annually. Other countries are keeping a close eye on Chinese-developed technology. iSOFT leveraged ‘China speed’ to establish CAPI’s foundation, allowing specifications and code to evolve in lockstep with shortened feedback cycles. AUTOSAR transcends geopolitical boundaries; this unified codebase will be used worldwide.”

Patrick Will, Head of SW Product Marketing & Management at Infineon, noted the accelerating transformation: “The open-source shift is accelerating and automotive mindsets are changing. iSOFT and Infineon are aligned in a shared vision: to streamline software development processes. Our DRIVECORE platform integrates iSOFT middleware with Infineon software and hardware layers, enabling customers to kick off their projects swiftly without encountering licensing barriers. ‘China-for-China’ development is increasingly essential, yet global collaboration matters — walls make no sense.”

Yu Peng, XPENG Motors Technical Center GM, explained CAPI’s value: “It delivers three key benefits for OEMs: reduced redundant costs, enhanced supply chain security, and accelerated ecosystem collaboration. CAPI solves the structural tension where foundational software moves too slowly while upper layers iterate in weeks. It provides a ‘common foundation’ for chip vendors, software suppliers, and automakers to co-develop on the same baseline. China’s mass-production practices now feed back into global standards while global standards better serve China.”

With 25 million-plus units deployed across 300-plus vehicle models, iSOFT’s OS brings production-proven middleware to the global stage through CAPI’s open, collaborative framework for the software-defined vehicle era.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/isoft-contributes-intelligent-driving-os-as-autosar-capi-global-code-baseline-302801042.html

SOURCE iSOFT

Continue Reading

Technology

METI-Supported Global South-Japan Tech Talent Internship Opens Applications for 2026 Program

Published

on

By

Program connects STEM students from the Global South with leading Japanese companies through on-site and online internships

TOKYO, June 16, 2026 /PRNewswire/ — Applications are now open for the Global South-Japan Tech Talent Internship (GS-JTI), a program sponsored by Japan’s Ministry of Economy, Trade and Industry (METI), with Deloitte Tohmatsu Venture Support Co., Ltd., serving as the Program Secretariat. The program aims to connect talented students and recent graduates from the Global South with Japanese companies in advanced technology fields, creating opportunities for cross-border learning, skills development, and future career growth.

The GS-JTI program is designed for students and recent graduates in STEM fields, including IT, AI, and semiconductors, who are interested in gaining real-world experience with Japanese industry. Through the program, selected participants will have the opportunity to work on meaningful projects, learn from industry mentors, and experience Japanese workplace culture.

In addition to practical work experience, the program offers various forms of participant support. These may include travel and accommodation support, visa application assistance, and 24/7 support during the internship period, in accordance with program conditions.

The program offers both on-site internships in Japan and online internship opportunities. On-site internships are scheduled for approximately 1.5 months between September 2026 and February 2027, while online internships are scheduled for approximately one month during the same period, subject to host company conditions.

Applicants must satisfy the program’s eligibility requirements. Eligible candidates include individuals who:

are majoring in STEM-related fields, including IT, AI, and semiconductors.are currently enrolled at a university or have graduated within the last three years.possess working proficiency in English.are citizens of countries listed on the OECD DAC List (excluding the People’s Republic of China); andreside outside Japan at the time of application.

Past program feedback indicates strong participant interest in future engagement with Japanese employers. According to program materials, 94% of previous interns expressed interest in working for Japanese companies after completing the internship.

The GS-JTI program seeks to contribute to skills development, cross-cultural exchange, and longer-term collaboration between Japan and future technology professionals from the Global South.

For additional information about the program, please visit:
** https://gs-jti.go.jp/foreign-talent/**

To register and apply, please visit:
** https://hub.techjapan.work/register**

Contact
Global South – Japan Tech Talent Internship (GS-JTI) Program Secretariat
(Contractor: Deloitte Tohmatsu Venture Support Co., Ltd.)
Email address: gs_hr_exchange_support@tohmatsu.co.jp

View original content:https://www.prnewswire.com/apac/news-releases/meti-supported-global-south-japan-tech-talent-internship-opens-applications-for-2026-program-302797841.html

SOURCE DELOITTE TOHMATSU VENTURE SUPPORT CO., LTD.

Continue Reading

Technology

U.S. News Unveils 2026-2027 Best Global Universities Rankings

Published

on

By

Universities in more than 100 countries are evaluated in the newest edition.

WASHINGTON, June 16, 2026 /PRNewswire/ — U.S. News & World Report, the global authority in education rankings and consumer advice, today published the 2026-2027 Best Global Universities rankings, which evaluate more than 2,250 schools on academic research and reputation.

The latest edition includes universities from more than 100 countries. The following countries have the most schools in the overall rankings:

China: 409United States: 275India: 123United Kingdom: 93Japan: 86

“For students seeking universities with strong academic excellence and global recognition, the Best Global Universities rankings offer an essential comparative resource,” said LaMont Jones, Ed.D., managing editor for Education at U.S. News. “Our methodology focuses on a school’s research mission and scholarly impact, helping students identify institutions that are truly at the forefront of global knowledge creation.”

Of the 51 subject rankings, four will have more schools ranked this year, including: water resources; chemical engineering; energy and fuels; and clinical medicine.

Powered by data and metrics from the Web of Science Core Collection and InCites Benchmarking & Analytics provided by Clarivate, a leading global provider of transformative intelligence, the Best Global Universities methodology weighs factors that measure a university’s global and regional research reputation and academic research performance.

For the overall ranking, this includes bibliometric indicators such as publications, citations and international collaboration. Each of the 51 subject rankings has its own weighting based on academic research performance in that specific area.

2026-2027 U.S. News & World Report Best Global Universities
*See the full rankings here.

Overall Best Global Universities – Top 10

Harvard UniversityMassachusetts Institute of Technology (MIT)Stanford UniversityUniversity of OxfordUniversity of CambridgeTsinghua UniversityUniversity of California BerkeleyYale UniversityUniversity College LondonColumbia University

Africa – Top 3

University of Cape Town (South Africa)Cairo University (Egypt)University of Witwatersrand (South Africa)

Asia – Top 3

Tsinghua University (China)National University of Singapore (Singapore)Peking University (China)

Australia/New Zealand – Top 3

University of Melbourne (Australia)University of Sydney (Australia)University of New South Wales Sydney (Australia)

Europe – Top 3

University of Oxford (United Kingdom)University of Cambridge (United Kingdom)University College London (United Kingdom)

Latin America – Top 3

Universidade de Sao Paulo (Brazil)Pontificia Universidad Catolica de Chile (Chile)University of Buenos Aires (Argentina)

The Best Global Universities rankings serve the broader U.S. News mission of providing trusted information and rankings – such as Best High Schools, Best Colleges and Best Online Programs – to empower all students in making informed choices about their education.

For more information on the Best Global Universities, visit X, TikTok, Facebook and Instagram using #BestGlobal.

About U.S. News & World Report

U.S. News & World Report is the global leader for journalism that empowers consumers, citizens, business leaders and policy officials to make confident decisions in all aspects of their lives and communities. A multifaceted media company, U.S. News provides unbiased rankings, independent reporting and analysis, and consumer advice to millions of people on USNews.com each month. A pillar in Washington for more than 90 years, U.S. News is the trusted home for in-depth and exclusive insights on education, health, politics, the economy, insurance, personal finance, travel, automobiles, real estate, careers and consumer products and services.

About Clarivate

Clarivate is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/us-news-unveils-2026-2027-best-global-universities-rankings-302800745.html

SOURCE U.S. News & World Report, L.P.

Continue Reading

Trending